Dealing Room Buzz: Sun Pharma, JSPL, Karnataka Bank, Lupin

MUMBAI: ET Now spoke to dealers on institutional and high net worth investors’ activity in the dealing room. Following stocks were on their radar on unconfirmed reports.

Sun Pharma:

Dealers expect the stock to move higher after its competitor Himka Pharma raised Doxycycline guidance to $230 million from $200 million. Macquarie says, Sun Pharmaceuticals is likely to benefit via URL Pharma from doxycycline.

The stock was at Rs 237.30, up 2.53 per cent, on the BSE. It touched a high of Rs 244.75 and a low of Rs 233.50 in trade today.

JSPL:

Dealers say majority of the selling in JSPL is expected to be over today. They continue to be bullish on the metals sector.

The stock was at Rs 237.30, up 2.53 per cent, on the BSE. It touched a high of Rs 244.75 and a low of Rs 233.50 in trade today.

Karnataka Bank:

Desks indicate HNI accumulation in the stock.

The stock was at Rs 76.60, up 0.26 per cent, on the BSE. It touched a high of Rs 78.40 and a low of Rs 75.80 in trade today.

United Spirits:

Dealers Say domestic funds are buyers in trade today. They expect the stock to touch levels of Rs 2,250

The stock was at Rs 2,198, up 2.03 per cent, on the BSE. It touched a high of Rs 2,234.90 and a low of Rs 2,135 in trade today.

Lupin:

Dealers indicate that a fund is buying the stock at lower levels.

The stock was at Rs 790.25, up 1.55 per cent, on the BSE. It touched a high of Rs 799.35 and a low of Rs 769.55 in trade today.

IGL:

Dealers suggest buying the stock for target of Rs 280-285

The stock was at Rs 269, up 2.01 per cent, on the BSE. It touched a high of Rs 273.60 and a low of Rs 265 in trade today.

Disclaimer:

The above report is based on market buzz and information given by dealers. Please consult your financial advisor before taking any position in the stocks mentioned.